← Back to Clinical Trials
Recruiting NCT04330456

Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy

Trial Parameters

Condition Soft Tissue Sarcoma Adult
Sponsor N.N. Petrov National Medical Research Center of Oncology
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2020-02-01
Completion 2022-07-01
Interventions
Preoperative stereotactic radiation therapy in hypofractionation modeSurgeryPostoperative conformal radiation therapy in normofractionation mode

Brief Summary

Combined treatment of soft tissue sarcoma includes 3 steps: 1. step - preoperative stereotactic radiation therapy in hypofractionation mode 2. step - operation 3. step - postoperative conformal radiation therapy in normofractionation mode

Eligibility Criteria

Inclusion Criteria: * morphologically verified diagnosis of soft tissue sarcoma * first diagnosed tumor process * ability to perform radical surgery * signed informed consent * indications for stereotactic and conformal radiation therapy * no contraindications for radiation and surgical treatment Exclusion Criteria: * previous radiation treatment * acute infection * pregnancy, lactation * recurrent tumor * refuse to sign informed consent * conditions that can affect the outcome of treatment (immunodeficiency, tuberculosis, etc.) * tumor topography and volume that don't allow to perform stereotactic and conformal radiation therapy.

Related Trials